Marker Therapeutics is trading at $1.03 (-7.54%) in after-hours trading as a broader risk-off market backdrop and Fed-related sentiment weigh on the stock.
- The decline follows a closing price of $1.11 on July 29, 2026, with no major company-specific announcements identified to explain the move.
- The price action appears consistent with thin after-hours liquidity and general weakness across major U.S. indices following the recent Fed decision.